Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock)
AT ˙ WBAG ˙ US8816242098
29,40 € ↑1,40 (5,00%)
2026-06-04
PREZZO DELLE AZIONI
SecurityAT:TEVA / Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock)
InstitutionCss Llc/il
Latest Disclosed Ownership27,070 shares
Latest Disclosed Value $ 815,348
Css Llc/il ownership in TEVA / Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock)

On May 15, 2026 - Css Llc/il filed a 13F-HR form disclosing ownership of 27,070 shares of Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock) (AT:TEVA) valued at $684,871 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 27,070 shares of Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock). This represents a change in shares of 0.00% during the quarter. The current value of the position is $795,858 USD.

Css Llc/il has a history of taking positions in derivatives of the underlying security (TEVA) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

AT:TEVA / Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock) Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 27,070 0 0.00 815 -3.44 0.0391
2026-02-17 2025-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 27,070 -7,480 -21.65 845 21.09 0.0376
2025-11-13 2025-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 34,550 34,550 698 0.0313
2025-08-14 2025-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 0 -27,100 -100.00 0 -100.00
2025-05-15 2025-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 27,100 27,100 417 0.0229
2020-05-15 2020-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 0 -3,039 -100.00 0 -100.00
2020-02-14 2019-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 3,039 -12,500 -80.44 30 -71.96 0.0017
2019-11-14 2019-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 15,539 7,500 93.30 107 44.59 0.0069
2019-08-14 2019-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 8,039 8,039 74 0.0043
2019-05-15 2019-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADR 881624209 0 -25,000 -100.00 0 -100.00
2019-02-14 2018-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADR 881624209 25,000 25,000 386 0.0259
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-08-14 2025-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-05-15 2025-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Call 20,000 307 n/a n/a n/a
2018-08-14 2018-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADR Call 0 -100.00 0 -100.00 n/a n/a n/a
2018-05-15 2018-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADR Call 40,000 -34.32 684 -40.73 n/a n/a n/a
2018-02-14 2017-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADR Call 60,900 1,154 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2020-05-15 2020-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-02-14 2019-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Put 30,000 0.00 294 42.03 n/a n/a n/a
2019-11-14 2019-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Put 30,000 0.00 207 -25.27 n/a n/a n/a
2019-08-14 2019-06-30 13F TEVA PHARMACEUTICAL INDS COM Put 30,000 0.00 277 -41.19 n/a n/a n/a
2019-05-15 2019-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Put 30,000 -83.33 471 -83.02 n/a n/a n/a
2019-02-14 2018-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADR Put 180,000 20.00 2,774 -14.12 n/a n/a n/a
2018-11-14 2018-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADR Put 150,000 0.00 3,230 -11.43 n/a n/a n/a
2018-08-14 2018-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADR Put 150,000 -6.25 3,647 33.30 n/a n/a n/a
2018-05-15 2018-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADR Put 160,000 45.45 2,736 31.10 n/a n/a n/a
2018-02-14 2017-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADR Put 110,000 171.60 2,087 192.71 n/a n/a n/a
2017-11-14 2017-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADR Put 40,500 713 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.